Trial Outcomes & Findings for Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery (NCT NCT02836990)
NCT ID: NCT02836990
Last Updated: 2020-12-28
Results Overview
The primary effectiveness endpoint is 30 day healing of the randomized groin incision, with any wound infection or failure to heal. Szilagyi wound infection grade quantified on an ordinal scale will be used to assess the healing (None, Grade I: Infection contained to the dermis, Grade II: Infection extending into the subcutaneous tissue but the arterial graft is not involved, Grade III: Infection of the arterial graft or native vessel underlying the incision). Healing is assessed by complete sealing of the incision with no residual separation or drainage. All of the incisions were primarily closed, so a healed incision would have no gaps between the skin edges. This is a visual inspection. Szilagi is an assessment of the grade of wound infection for those that did not heal. It is well recognized and published, and noted as above for patients with vascular exposure.
COMPLETED
NA
105 participants
30 days
2020-12-28
Participant Flow
Participants were recruited from UBMD Vascular Surgery Office and were consented at the time of surgery at Buffalo General Medical Center between 2016 and 2019.
Participant milestones
| Measure |
Prevena
Prevena Incision Management System for vascular surgical groin wounds
Prevena Incision Management System: A negative pressure system which holds incision edges together and removes exudate and debris from site to prevent surgical wound infections
|
Dermabond
Dermabond for vascular surgical groin wounds
Dermabond: A surgical skin adhesive used to prevent surgical wound infections
|
|---|---|---|
|
Overall Study
STARTED
|
50
|
55
|
|
Overall Study
COMPLETED
|
50
|
55
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Prevena™ vs Dermabond in Groin Wound Infections in Vascular Surgery
Baseline characteristics by cohort
| Measure |
Prevena
n=46 Participants
Prevena Incision Management System for vascular surgical groin wounds
Prevena Incision Management System: A negative pressure system which holds incision edges together and removes exudate and debris from site to prevent surgical wound infections
|
Dermabond
n=55 Participants
Dermabond for vascular surgical groin wounds
Dermabond: A surgical skin adhesive used to prevent surgical wound infections
|
Total
n=101 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=113 Participants
|
0 Participants
n=163 Participants
|
0 Participants
n=160 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
16 Participants
n=113 Participants
|
20 Participants
n=163 Participants
|
36 Participants
n=160 Participants
|
|
Age, Categorical
>=65 years
|
30 Participants
n=113 Participants
|
35 Participants
n=163 Participants
|
65 Participants
n=160 Participants
|
|
Age, Continuous
|
68 years
STANDARD_DEVIATION 10 • n=113 Participants
|
68 years
STANDARD_DEVIATION 12 • n=163 Participants
|
68 years
STANDARD_DEVIATION 11 • n=160 Participants
|
|
Sex: Female, Male
Female
|
21 Participants
n=113 Participants
|
15 Participants
n=163 Participants
|
36 Participants
n=160 Participants
|
|
Sex: Female, Male
Male
|
25 Participants
n=113 Participants
|
40 Participants
n=163 Participants
|
65 Participants
n=160 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=113 Participants
|
0 Participants
n=163 Participants
|
0 Participants
n=160 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=113 Participants
|
0 Participants
n=163 Participants
|
0 Participants
n=160 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=113 Participants
|
0 Participants
n=163 Participants
|
0 Participants
n=160 Participants
|
|
Race (NIH/OMB)
Black or African American
|
10 Participants
n=113 Participants
|
4 Participants
n=163 Participants
|
14 Participants
n=160 Participants
|
|
Race (NIH/OMB)
White
|
36 Participants
n=113 Participants
|
51 Participants
n=163 Participants
|
87 Participants
n=160 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=113 Participants
|
0 Participants
n=163 Participants
|
0 Participants
n=160 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=113 Participants
|
0 Participants
n=163 Participants
|
0 Participants
n=160 Participants
|
|
Region of Enrollment
United States
|
46 participants
n=113 Participants
|
55 participants
n=163 Participants
|
101 participants
n=160 Participants
|
PRIMARY outcome
Timeframe: 30 daysThe primary effectiveness endpoint is 30 day healing of the randomized groin incision, with any wound infection or failure to heal. Szilagyi wound infection grade quantified on an ordinal scale will be used to assess the healing (None, Grade I: Infection contained to the dermis, Grade II: Infection extending into the subcutaneous tissue but the arterial graft is not involved, Grade III: Infection of the arterial graft or native vessel underlying the incision). Healing is assessed by complete sealing of the incision with no residual separation or drainage. All of the incisions were primarily closed, so a healed incision would have no gaps between the skin edges. This is a visual inspection. Szilagi is an assessment of the grade of wound infection for those that did not heal. It is well recognized and published, and noted as above for patients with vascular exposure.
Outcome measures
| Measure |
Prevena
n=46 Participants
Prevena Incision Management System for vascular surgical groin wounds
Prevena Incision Management System: A negative pressure system which holds incision edges together and removes exudate and debris from site to prevent surgical wound infections
|
Dermabond
n=55 Participants
Dermabond for vascular surgical groin wounds
Dermabond: A surgical skin adhesive used to prevent surgical wound infections
|
|---|---|---|
|
Comparison of Healing of Groin Wounds Between Patients Treated With Prevena vs Dermabond
|
41 Participants
|
54 Participants
|
SECONDARY outcome
Timeframe: 30 daysPopulation: not analyzed as the primary outcome did not demonstrate improved outcomes, and the device being tested, wound vacuum, was more expensive. Had outcomes clinically been improved, financial assessment would have determined whether cost of infection outweighed cost of device.
Comparison of cost of treatment between the two arms
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 30 daysPhysician office visits for diagnosis of Infection or visiting nurse visits for diagnosis of infection ONLY were assessed.
Outcome measures
| Measure |
Prevena
n=46 Participants
Prevena Incision Management System for vascular surgical groin wounds
Prevena Incision Management System: A negative pressure system which holds incision edges together and removes exudate and debris from site to prevent surgical wound infections
|
Dermabond
n=55 Participants
Dermabond for vascular surgical groin wounds
Dermabond: A surgical skin adhesive used to prevent surgical wound infections
|
|---|---|---|
|
Number of Visiting Nurses Home Visits and Physician Office Visits to Assess/Treat Wound Infection
|
7 Participants
|
7 Participants
|
Adverse Events
Prevena
Dermabond
Serious adverse events
| Measure |
Prevena
n=46 participants at risk
Prevena Incision Management System for vascular surgical groin wounds
Prevena Incision Management System: A negative pressure system which holds incision edges together and removes exudate and debris from site to prevent surgical wound infections
|
Dermabond
n=55 participants at risk
Dermabond for vascular surgical groin wounds
Dermabond: A surgical skin adhesive used to prevent surgical wound infections
|
|---|---|---|
|
Infections and infestations
Reoperation for groin complication
|
6.5%
3/46 • Number of events 5 • 40 days from time of surgery
|
3.6%
2/55 • Number of events 2 • 40 days from time of surgery
|
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place